Literature DB >> 17114515

18F-choline PET/CT for initial staging of advanced prostate cancer.

Fabrice Gutman1, Vanessa Aflalo-Hazan, Khaldoun Kerrou, Françoise Montravers, Dany Grahek, Jean-Noël Talbot.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17114515     DOI： 10.2214/AJR.05.0437

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN： 0361-803X            Impact factor:   3.959


× No keyword cloud information.
  3 in total

1.  Potential of hybrid ¹⁸F-fluorocholine PET/MRI for prostate cancer imaging.

Authors:  Thomas de Perrot; Olivier Rager; Max Scheffler; Martin Lord; Marc Pusztaszeri; Christophe Iselin; Osman Ratib; Jean-Paul Vallee
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-05-20       Impact factor: 9.236

2.  Targeting free prostate-specific antigen for in vivo imaging of prostate cancer using a monoclonal antibody specific for unique epitopes accessible on free prostate-specific antigen alone.

Authors:  Susan Evans-Axelsson; David Ulmert; Anders Örbom; Pernilla Peterson; Olle Nilsson; Johan Wennerberg; Joanna Strand; Karin Wingårdh; Tomas Olsson; Zandra Hagman; Vladimir Tolmachev; Anders Bjartell; Hans Lilja; Sven-Erik Strand
Journal:  Cancer Biother Radiopharm       Date:  2012-04-10       Impact factor: 3.099

3.  Target volume definition in high-risk prostate cancer patients using sentinel node SPECT/CT and 18 F-choline PET/CT.

Authors:  Hansjörg Vees; Charles Steiner; Giovanna Dipasquale; Amine Chouiter; Thomas Zilli; Michel Velazquez; Sophie Namy; Osman Ratib; Franz Buchegger; Raymond Miralbell
Journal:  Radiat Oncol       Date:  2012-08-08       Impact factor: 3.481
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.